This book chapter looks at the CMS-funded Informatics for Diabetes Education and Telemedicine demonstration. The chapter summarizes participants’ use of the technology, intervention effects on intermediate clinical outcomes, intervention effects on Medicare services’ use and cost, and...

This report summarizes the evaluation findings for the Electronic Health Records Demonstration (EHRD), funded and implemented by the Centers for Medicare & Medicaid Services (CMS). A large proportion of practices (43 percent) were unable or unwilling to meet program requirements to continue...

The IDEATel demonstration tested the effects of providing home-based telemedicine services to a large number of eligible Medicare beneficiaries who had diabetes and lived in medically underserved areas in New York City and upstate New York. This report updates two earlier reports to Congress and...

The IDEATel demonstration tested the effects of providing home-based telemedicine services to a large number of eligible Medicare beneficiaries who had diabetes and lived in medically underserved areas in New York City and upstate New York. This report updates two earlier reports to Congress and...

In October 2012, the Center for Medicare & Medicaid Innovation of the Centers for Medicare & Medicaid Services (CMS), in a unique collaboration between public and private health care payers, launched the Comprehensive Primary Care (CPC) initiative to improve primary care delivery in seven...

This articles examines interim impacts of a disease management demonstration for Medicare fee-for-service beneficiaries also enrolled in Medicaid (dual eligibles). The study randomly assigned dual eligibles with congestive heart failure, coronary artery disease, and/or diabetes to treatment or...

Before Medicare Part D, Congress authorized the Medicare disease management demonstration to evaluate whether disease management programs—in conjunction with a comprehensive prescription drug benefit—could improve health outcomes and reduce Medicare expenditures. The demonstration...

Before Medicare Part D, Congress authorized the Medicare disease management demonstration to evaluate whether disease management programs—in conjunction with a comprehensive prescription drug benefit—could improve health outcomes and reduce Medicare expenditures. The demonstration...

This articles examines interim impacts of a disease management demonstration for Medicare fee-for-service beneficiaries also enrolled in Medicaid (dual eligibles). The study randomly assigned dual eligibles with congestive heart failure, coronary artery disease, and/or diabetes to treatment or...